Ameritas Advisory Services LLC Acquires 3,179 Shares of iShares Biotechnology ETF $IBB

Ameritas Advisory Services LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 426.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,924 shares of the financial services provider’s stock after acquiring an additional 3,179 shares during the period. Ameritas Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $662,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. BNP Paribas Financial Markets lifted its holdings in shares of iShares Biotechnology ETF by 313.2% in the third quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock valued at $276,526,000 after purchasing an additional 1,451,820 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of iShares Biotechnology ETF by 27.2% in the third quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock valued at $153,039,000 after purchasing an additional 226,852 shares in the last quarter. Truist Financial Corp lifted its holdings in shares of iShares Biotechnology ETF by 2,239.6% in the fourth quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock valued at $108,354,000 after purchasing an additional 614,582 shares in the last quarter. WestEnd Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $106,276,000. Finally, Jefferies Financial Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $65,083,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $166.83 on Friday. The stock’s 50-day moving average is $169.24 and its 200-day moving average is $169.57. iShares Biotechnology ETF has a one year low of $118.51 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.